Lianying Medical Mai Lande and many other listing ｜ August Medical Capital Key

In August, the TOP10 institutions in the field of medical and health include Kaitai Capital, 8VC, Gao Rong Capital, Hui Each Capital, etc., Xuantai Pharmaceutical, Lianying Medical, Noser, Lianke Pharmaceutical, Mai Lande Yu 8 Monthly listed.

In conjunction with the current medical investment overview, Zhiwei Research Institute elaborates investment hotspots and related policies in August, and finally enumerates media views to provide reference for enterprises and institutions.

微️ Main pen/ Zhi Xiaowei

财 Production/ good medical financial & Zhiwei data

01

Overview of investment in the field of medical and health in August

Investment institution

A total of 316 investment institutions in the medical and health field invested 167. TOP investment institutions mainly include Kaitai Capital, 8VC, Gao Rong Capital, and Hui every capital.

Kaitai Capital, 8VC, Gao Rong Capital invested a total of 10 in the field of medical and health.

Situment of investing companies

Biotechnology and pharmaceutical, medical information, medical equipment and hardware are the most important investors' attention, and biotechnology and pharmaceutical sections account for more than half.

Investment companies include crystal nuclear creatures, Sheng Ruizhuhua, Gebo Bio, Vironaron Sironaxkeycare, Flossy, etc.

Investment company information in August

If you need to get detailed investment institutions and information about the investment enterprise, please check the complete report.

Listed enterprise situation

Xuantai Pharmaceutical, Lianying Medical, Nogg, Lianke Pharmaceutical, and Mai Lande were listed in August; Lianying Medical financing the most, reaching 10.99 billion yuan.

Listing corporate information in August

If you need to get the detailed listed company information, check the complete report.

Compared with the investment in July, the number and amount of investment in August continued to rise to 43.1 billion yuan, with an average investment of about 260 million yuan.

02

related policy

In August 2022, policies in the field of medical and health involve drug management, medical security, medical equipment and talent training, including:

1. Drug management aspect

"Announcement of the results of the National Pharmaceutical Concentrated Procurement"

Policy points: According to the information of the National Medical Security Bureau, 60 drugs are successfully procure in this collection. The average price reduction of drugs is 48%. According to the agreed purchase volume, it is expected to save 18.5 billion yuan per year.

"Notice on Further Strengthening the Safety Management of Medication and Improvement of Reasonable Drugs"

Policy points: Medical institutions should improve and implement the system of medication safety, improve the consciousness and ability of medical care and other personnel, and implement the entire process management of prescription, deployment, administration, and medication. Encourage medical institutions to use informatization methods to intelligently review and manage the entire process of clinical medication.

2. In terms of medical security

"Notice on Further Doing a Basic Medical Insurance Cross -Provincial Different Place for Medical Consolidation"

Policy points: The notice pointed out that before the end of 2025, the state -based medical settlement capacity was significantly improved. The direct settlement rate of inpatient expenses increased to more than 70%. The number of ordinary outpatient cross -provincial network -intensive pharmaceutical institutions doubled. Different places have a convenient regulation of medical treatment, and basically realize the online and offline medical insurance reimbursement.

3. Medical equipment

"Notice on the Special Governance of the Price Governance of Oral Planting Medical Services and Consumption (Draft for Solicitation of Opinions)"

Policy points: The draft for soliciting comments clearly proposes that one must standardize the method of oral planting medical services and consumables; the second is to strengthen the price control of medical services such as oral planting; the third is to carefully organize the centralized purchase of dental implants; Governance.

03

Media view

In August, some media expressed their views on topics such as medical treatment, new dental implants, medical drug guarantee, medical drug supervision and medical talents.

1. Medication for a different place

People's Daily Comment: The rapid development of socio -economic development, the movement of personnel has become the norm, the demand for medical treatment in different places is prominent, and medical insurance services must "advance with the times" to better meet the demands of the masses. If you actively carry out the pilot of direct settlement of medical treatment in different places is to solve "from scratch"; then, reforms are continuously deepened, experienced accumulation, and continuous coverage of coordinated coverage, it is necessary to achieve "from there to excellence", which facilitates the masses to a greater extent. Seek medical treatment abroad to further enhance the masses' sense of gain.

2. New dental implants

First Financial: Generally speaking, collection is aimed at the varieties that have been included in medical insurance, such as drug collection and equipment consumables, but as of now, the medical insurance fund has not yet covered dental implants, and dental implants are still belonging to the medical insurance foreign collection mining mining. The medical insurance bureau explores the new collection model is difficult and it takes a certain time. In addition, the previous procurement subject was usually a public hospital. However, the procurement subject of dental implants is a private hospital, which has also exacerbated the difficulty of dental implants.

China Securities Journal: Recently, the medical insurance bureau issued the notice of oral planting charges and medical services price surveys and registration, laying a foundation for subsequent implementation of dental implants and standardized oral planting medical services. People in the industry believe that dental implants will be accelerated, consumable cost adjustment and medical price specifications will be promoted simultaneously, and the penetration rate is expected to increase rapidly.

3. Medical and Drug Supervision

- END -